Testing effectiveness (Phase 2)Study completedNCT01135641
What this trial is testing
Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)
Who this might be right for
Graft Versus Host Disease
Nantes University Hospital 25